PRNB
Principia Biopharma Inc. Common Stock
PRNB
PRNB
Delisted
PRNB was delisted on the 25th of September, 2020.
74 hedge funds and large institutions have $671M invested in Principia Biopharma Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 30 increasing their positions, 11 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
+12
Holders Change %
+19.35%
% of All Funds
1.61%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
25
Increased
30
Reduced
11
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
$19.7M |
| 2 |
BlackRock
New York
|
$32.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$19.1M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
$8.1M |
| 5 |
State Street
Boston,
Massachusetts
|
$7.97M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
$53.3M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
$408K |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
$16.6M |
| 4 |
RI
RTW Investments
New York
|
$8.99M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
$0 |
